LONDON, ONTARIO--(Marketwire - April 07, 2008) - A correction from source is issued with respect to the release issued April 7, 2008 at 7:30 AM ET. The second to last sentence of the second paragraph of the release now contains the addition of broker information. The complete and corrected release is as follows: Stellar Pharmaceuticals Inc. (“Stellar”) (TSX VENTURE: SLX)(OTCBB: SLXCF) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice filed by Stellar of its intention to make a Normal Course Issuer Bid (the “Bid”).
